The WHO is urging people to wear masks again, even if they're vaccinated. An infectious diseases expert explains whether its time for the US to mask up.
BioNTech plans to start clinical testing by the end of 2022 for a new malaria vaccine, which aims to make the parasite visible and attackable when it enters the body.
The lambda variant accounts for 97% of COVID-19 cases in Peru. The variant contains many mutations, which could increase transmissibility and severity.
Lack of internet access is affecting vaccine uptake among older and vulnerable populations. What steps should governments take to improve digital access?
The world is facing a worsening two-track recovery, driven by dramatic differences in vaccine availability, infection rates, and the ability to provide policy support.
Officials around the world are incentivising citizens to get a COVID-19 vaccine, including opening raffles to win cars and offering a $1.5 million lottery.
With the Delta variant gaining ground, here’s how scientists track down new strains as the COVID virus mutates, with potentially higher risks to health.
With vaccination programmes progressing in many parts of the world, some people are more ready than others to relax restrictions, a new survey finds.
What's inside an mRNA vaccine vial? How do mRNA vaccines differ from other approaches, and what’s their promise for the future?
Public-private partnerships could address many of the problems related to getting COVID-19 vaccine doses to low-connectivity, resource-starved regions.
To achieve herd immunity to COVID-19, officials need to focus on thoughts and feelings rather than distribution. Information and incentives will be key.
Half of all vaccines available by June 2021 were reserved by rich countries, who represent one seventh of the global population, writes a health expert.
Filippo Grandi, the UN High Commissioner for Refugees, believes inequities around COVID-19 vaccinations are immoral, resolvable, and ultimately impact us all.
Between 48% and 56% of people in wealthy countries support donating part of their country's vaccine stockpile across the world, according to a new study.
The G7 are to donate a billion COVID-19 vaccine doses to poorer countries, but some experts fear it offers only a small lifeline to global vaccine equity.